@article{MTMT:34133554, title = {Treatment of In-stent Restenosis of the Internal Carotid Artery Using Drug-eluting Balloons}, url = {https://m2.mtmt.hu/api/publication/34133554}, author = {Marton, Annamária and Blényesi, Eszter and Török, Katalin and Balogh, Gábor and Gubucz, István and Nardai, Sándor and Lenzsér, Gábor and Nagy, Csaba Balázs and Bajzik, Gábor and Tollár, József and Repa, Imre and Nagy, Ferenc and Vajda, Zsolt}, doi = {10.1007/s00062-023-01343-6}, journal-iso = {CLIN NEURORADIOL}, journal = {CLINICAL NEURORADIOLOGY}, volume = {34}, unique-id = {34133554}, issn = {1869-1439}, keywords = {Stent; Restenosis; intervention; Carotid; Drug-eluring balloons}, year = {2024}, eissn = {1869-1447}, pages = {147-154}, orcid-numbers = {Marton, Annamária/0000-0002-6826-6695; Bajzik, Gábor/0000-0002-0996-9294; Tollár, József/0000-0001-7607-6739} } @article{MTMT:33314224, title = {Shall We Screen Lung Cancer With Low-Dose Computed Tomography? Cost-Effectiveness in Hungary}, url = {https://m2.mtmt.hu/api/publication/33314224}, author = {Nagy, Balázs and Szilberhorn, László and Győrbíró, Dávid M. and Moizs, Mariann and Bajzik, Gábor and Kerpel-Fronius, Anna and Vokó, Zoltán}, doi = {10.1016/j.vhri.2022.10.002}, journal-iso = {VAL HEALTH REG ISS}, journal = {VALUE IN HEALTH REGIONAL ISSUES}, volume = {34}, unique-id = {33314224}, issn = {2212-1099}, keywords = {Hungary; PREVENTION; public health; lung cancer; Cost-effectiveness; low-dose computed tomography screening}, year = {2023}, eissn = {2212-1102}, pages = {55-64}, orcid-numbers = {Nagy, Balázs/0000-0003-4125-7905; Moizs, Mariann/0000-0003-1055-5918; Bajzik, Gábor/0000-0002-0996-9294; Vokó, Zoltán/0000-0002-1004-1848} } @article{MTMT:34041888, title = {COST-EFFECTIVENESS OF LUNG CANCER SCREENING WITH LOW DOSE COMPUTED TOMOGRAPHY IN HUNGARY}, url = {https://m2.mtmt.hu/api/publication/34041888}, author = {Nagy, B. and Szilberhorn, L. and Gyorbira, D. and Moizs, Mariann and Bajzik, Gábor and Kerpel-Fronius, A. and Voko, Z.}, journal-iso = {VALUE HEALTH}, journal = {VALUE IN HEALTH}, volume = {25}, unique-id = {34041888}, issn = {1098-3015}, year = {2022}, eissn = {1524-4733}, pages = {S118-S118}, orcid-numbers = {Moizs, Mariann/0000-0003-1055-5918; Bajzik, Gábor/0000-0002-0996-9294} } @article{MTMT:33062483, title = {Akut ischaemiás stroke neurointervenciós kezelése: kaposvári tapasztalatok}, url = {https://m2.mtmt.hu/api/publication/33062483}, author = {Marton, Annamária and Nagy, Csaba Balázs and Lenzsér, Gábor and Nardai, Sándor and Gubucz, István and Bajzik, Gábor and Nagy, Ferenc and Vajda, Zsolt}, journal-iso = {IDEGGYÓGY SZEMLE PROC}, journal = {IDEGGYÓGYÁSZATI SZEMLE PROCEEDINGS / CLINICAL NEUROSCIENCE PROCEEDINGS}, volume = {7}, unique-id = {33062483}, issn = {2498-6240}, year = {2022}, pages = {156-157}, orcid-numbers = {Marton, Annamária/0000-0002-6826-6695; Bajzik, Gábor/0000-0002-0996-9294} } @article{MTMT:32788547, title = {PET/MRI in the Presurgical Evaluation of Patients with Epilepsy: A Concordance Analysis}, url = {https://m2.mtmt.hu/api/publication/32788547}, author = {Borbély, Katalin and Emri, Miklós and Kenessey, István and Tóth, Márton and Singer, Júlia and Barsi, Péter and Vajda, Zsolt and Pál, Endre and Tóth, Zoltán and Beyer, Thomas and Dóczi, Tamás Péter and Bajzik, Gábor and Fabó, Dániel and Janszky, József Vladimír and Jordán, Zsófia and Fajtai, Dániel and Kelemen, Anna and Juhos, Vera and Wintermark, Max and Nagy, Ferenc and Moizs, Mariann and Nagy , Dávid Gergő and Lückl, János and Repa, Imre}, doi = {10.3390/biomedicines10050949}, journal-iso = {BIOMEDICINES}, journal = {BIOMEDICINES}, volume = {10}, unique-id = {32788547}, keywords = {epilepsy surgery; presurgical evaluation; Concordance analysis; metabolic PET; Preoperative workflow; medically refractory focal epilepsy; MRI-negative patients; discordant electroclinical and MRI data; hybrid [18F]-FDG PET/MRI; epilepsy team}, year = {2022}, eissn = {2227-9059}, orcid-numbers = {Borbély, Katalin/0000-0002-1675-4128; Kenessey, István/0000-0002-6963-8489; Barsi, Péter/0000-0002-3574-9973; Tóth, Zoltán/0000-0002-8096-3813; Bajzik, Gábor/0000-0002-0996-9294; Fabó, Dániel/0000-0001-5141-5351; Janszky, József Vladimír/0000-0001-6100-832X; Fajtai, Dániel/0000-0001-7591-3101; Kelemen, Anna/0000-0003-3942-3409; Moizs, Mariann/0000-0003-1055-5918; Lückl, János/0000-0001-8094-771X} } @article{MTMT:32228684, title = {Endovascular Recanalization of Tandem Internal Carotid Occlusions Using the Balloon-assisted Tracking Technique}, url = {https://m2.mtmt.hu/api/publication/32228684}, author = {Nagy, Csaba Balázs and Héger, Júlia and Balogh, Gábor and Gubucz, István and Nardai, Sándor and Lenzsér, Gábor and Bajzik, Gábor and Fehér, Máté and Moizs, Mariann and Repa, Imre and Nagy, Ferenc and Vajda, Zsolt}, doi = {10.1007/s00062-021-01078-2}, journal-iso = {CLIN NEURORADIOL}, journal = {CLINICAL NEURORADIOLOGY}, volume = {32}, unique-id = {32228684}, issn = {1869-1439}, abstract = {Tandem occlusive lesions are responsible for up to 20% of acute ischemic stroke cases and are associated with poor prognosis if complete recanalization cannot be achieved. Endovascular recanalization might be challenging due to difficulties in the safe passage of the occluded plaque at the origin of the internal carotid artery (ICA). The balloon-assisted tracking technique (BAT), where a partially deflated balloon is exposed out of the catheter tip to facilitate its passage through stenosed or spastic arterial segments was introduced by interventional cardiologists and the applicability of the technique has been recently proposed in the field of neurointervention as well. Here we describe our experience using the BAT technique in the endovascular recanalization of tandem occlusive lesions.Procedures were performed from June 2013 to December 2020 in a single center. Baseline clinical and imaging data, procedural and follow-up details and clinical outcomes were retrospectively collected.In this study 107 patients, median age 66 years, median admission NIHSS 14 and median ASPECTS 8 were included. Successful recanalization of the ICA using the BAT technique was achieved in 100 (93%) and successful intracranial revascularization in 88 (82%) patients. There were no complications attributable to the BAT technique. Intraprocedural complications occurred in 9 (8%) patients. Emergent stenting was performed in 40 (37%) at the end of the procedure. Postprocedural adverse events (intracerebral hemorrhage [ICH], malignant infarction) occurred in 6 (5%) patients. Good clinical outcome at 3 months (modified Rankin scale [mRS] 0-2) was 54 (50%) and mortality 26 (24%). Delayed stent placement during follow-up occurred in 21 cases.Application of BAT technique in tandem occlusions appears feasible, safe, and efficient. Further evaluation of this technique is awaited.}, keywords = {technique; stroke; Stent; Thrombectomy; intervention}, year = {2022}, eissn = {1869-1447}, pages = {375-384}, orcid-numbers = {Bajzik, Gábor/0000-0002-0996-9294; Moizs, Mariann/0000-0003-1055-5918} } @article{MTMT:32074348, title = {A kis dózisú komputertomográfiával történő tüdőrákszűrés költségvetési hatása}, url = {https://m2.mtmt.hu/api/publication/32074348}, author = {Nagy, Balázs and Szilberhorn, László and Kerpel-Fronius, Anna and Moizs, Mariann and Bajzik, Gábor and Vokó, Zoltán}, doi = {10.1556/650.2021.32095}, journal-iso = {ORV HETIL}, journal = {ORVOSI HETILAP}, volume = {162}, unique-id = {32074348}, issn = {0030-6002}, abstract = {Összefoglaló. Bevezetés: Korábbi vizsgálatunk szerint a kis dózisú komputertomográfiával évente végzett tüdőrákszűrés 50-74 éves dohányzók körében költséghatékony, és az 55-74 évesek körében költségmegtakarító. Célkitűzés: Ennek a vizsgálatnak a célja a korábbi hosszú távú költséghatékonysági elemzés kiegészítése egy finanszírozó szempontú, rövid és középtávú költségvetési hatásvizsgálattal. Módszer: Egészség-gazdaságtani modellünk az 50-74 éves, naponta dohányzó lakosság tüdőrákszűrésének költségét hasonlítja össze a szervezett szűrésben nem részesülő, naponta dohányzó lakosság költségével. Ehhez megvizsgáljuk a célpopuláció létszámának alakulását, az eredményes elérés és felfedezés valószínűségét, továbbá a szűrés nyomán felmerülő terápiás költségeket és megtakarításokat. A szűrés és a kivizsgálások után diagnosztizált betegek útját az érvényben lévő hazai ellátási protokollnak megfelelően követjük. A kezelések eredményességét a HUNCHEST-felmérés adatai alapján, a kezelésekhez tartozó beavatkozások költségét közfinanszírozási adatok alapján számoljuk. Eredmények: A kis dózisú komputertomográfiával történő tüdőrákszűrés az érintett lakosság 10%-ának várható részvétele mellett a kezdeti évben mintegy 3,3 milliárd, az 5. évben 1,9 milliárd Ft éves többletkiadással jár. A 3. évig szűréssel felfedezett betegek terápiája többe kerül, mint a szűrés nélkülieké, ugyanakkor a 4. és 5. évben a szűrés nélküli csoportban a későbbi stádiumban felismert betegek kezelési költsége már meghaladja a szűrt betegek terápiás költségét. A 3. évtől folyamatosan növekvő terápiás megtakarítás a teljes szűrés költségét a 10. évre az 1. év kiadásának 20%-ára csökkenti. Következtetések: A kis dózisú komputertomográfiával történő tüdőrákszűrés bevezetése évi 2,6 milliárd Ft többletforrást igényelne, és folyamatos kiadáscsökkenés mellett hosszú távon akár nettó megtakarítást is eredményezhet a nem szervezett szűréshez képest. A kockázati csoportok pontosítása, például kiemelt földrajzi területeken végzett célzott szűrés tovább javíthatja az eredményeket. Orv Hetil. 2021; 162(24): 952-959.Our earlier analysis indicated that screening lung cancer patients with low-dose computed tomography amongst smokers between age of 50-74 and between age of 55-74 is cost-effective and cost-saving, respectively.This study aims to extend the long-term cost-effectiveness analysis with short- and mid-term budget impact analysis.The health economic model compares the cost of nationwide screening amongst smokers between 50-74 years to the current occasional screening policy. The analysis determines the size of the target population, recruitment rates and market uptake. Health care finance costs associated with the patient pathways are determined by national guidelines and clinical practice. Screening and treatment effectiveness are based on the HUNCHEST survey and international scientific literature, while the cost of health states and events are determined using national tariffs.Assuming 10% uptake of low-dose computed tomography screening for the target population will cost an additional 3.3 billion HUF and 1.9 billion HUF in the 1st and 5th years, respectively. Until the 3rd year, new patients' treatment costs exceed costs due to late discovery and delay in treatment. This pattern is changing from the 4th year on. Due to timely care savings by the 10th year in the screened population will reduce total costs to the 20% of the first year costs.Introduction of national screening for lung cancer patients with low-dose computed tomography is estimated to cost around additional 2.6 billion HUF/year and could end up in net savings in the long run. Identification of risk groups according to regional or other strata could increase the effectiveness and efficiency of the program. Orv Hetil. 2021; 162(24): 952-959.}, keywords = {Mass Screening; economic evaluation; lung cancer; Cost analysis; Költségelemzés; low-dose computed tomography; tüdőrák; gazdasági értékelés; kis dózisú komputertomográfia; tömeges szűrés}, year = {2021}, eissn = {1788-6120}, pages = {952-959}, orcid-numbers = {Nagy, Balázs/0000-0003-4125-7905; Kerpel-Fronius, Anna/0000-0002-8616-3366; Moizs, Mariann/0000-0003-1055-5918; Bajzik, Gábor/0000-0002-0996-9294; Vokó, Zoltán/0000-0002-1004-1848} } @article{MTMT:31968639, title = {Malignus májelváltozás képében megjelenő alveolaris echinococcosis három eset bemutatása kapcsán [Alveolar echinococcosis in the form of malignant liver changes in connection with the presentation of three cases]}, url = {https://m2.mtmt.hu/api/publication/31968639}, author = {Haragh, Attila and Magyarosi, D. and Pap, Ákos and Káposztás, Zsolt and Bajzik, Gábor and Czoma, V. and Csulak, Eszter and Szinku, Z. and Dezsényi, Balázs and Tóth, Zoltán and Hunyady, Béla}, journal-iso = {CENT EUR J GASTRO HEPATOL}, journal = {CENTRAL EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY / GASZTROENTEROLÓGIAI ÉS HEPATOLÓGIAI SZEMLE}, volume = {7}, unique-id = {31968639}, keywords = {albendazole; Echinococcus; májdaganatok; alveolaris echinococcosis}, year = {2021}, eissn = {2415-9107}, pages = {78-84}, orcid-numbers = {Bajzik, Gábor/0000-0002-0996-9294; Tóth, Zoltán/0000-0002-8096-3813} } @article{MTMT:31872892, title = {Predictive value of PET/CT based metabolic information in the modern 3D based radiotherapy treatment of head and neck can-cer patients - single institute study}, url = {https://m2.mtmt.hu/api/publication/31872892}, author = {Cselik, Zsolt and Tóth, Zoltán and Kedves, András and Sipos, Dávid and Freihat, Omar and Vecsera, Tímea and Lukács, Gábor and Emri, Miklós and Bajzik, Gábor and Hadjiev, Janaki and Repa, Imre and Moizs, Mariann and Kovács, Árpád}, doi = {10.1967/s002449912207}, journal-iso = {HELL J NUCL MED}, journal = {HELLENIC JOURNAL OF NUCLEAR MEDICINE}, volume = {23}, unique-id = {31872892}, issn = {1790-5427}, abstract = {The aim of the study was to evaluate the predictive value of pretreatment positron emission tomography (PET) standardized uptake value (SUVmax), standardized uptake value corrected for lean body mass (SULpeak) value, metabolic tumour volume (MTV) and total lesion glycolysis (TLG) parameters of the primary tumour assessed with PET/computed tomography (CT) in the clinical out-come in patients diagnosed with histopathologically confirmed head and neck squamous cell carcinoma.Retrospective evaluation was performed using PET/CT image datasets of 52 histologically proven head and neck cancer patients in 4 weeks' prior receiving definitive chemo-radiotherapy (CRT). Positron emission tomography /CT was performed before the CRT and 12 weeks after it for response evaluation. Image data was used for target volume delineation and for specify SUVmax, SULpeak, MTV and TLG parameters of the primary tumour. According to the results of the therapeutic response evaluation two patient subgroups were created in relation to the presence or absence of viable tumour. Metabolic data from pre-treatment PET/CT and therapeutic response were correlated using Kruskal-Wallis test.After completion of the CRT in 24/52 (46%) cases viable residual tumour was detected on restaging PET/CT, while in 28/52 (54%) patients showed complete remission. For the therapeutic success prediction assessment, we could not find any significant correlation with pre-treatment SUVmax and SULpeak values (P>0.44, P>0.33). Total lesion glycolysis provided nearly significant difference (P=0.052) and MTV had shown significant difference (P=0.001) between the two patient subgroups statistically.Simple metabolic data (SUVmax and SULpeak) from pretreatment fluorine-18-fluorodeoxyglucose (18F-FDG) PET/CT were unable to predict therapeutic response, while volumetric information containing MTV and TLG parameters proved to be more useful, thus their inclusion to risk stratification may also have additional value.}, year = {2020}, pages = {290-295}, orcid-numbers = {Cselik, Zsolt/0000-0003-2090-4632; Sipos, Dávid/0000-0001-9615-1740; Bajzik, Gábor/0000-0002-0996-9294; Hadjiev, Janaki/0000-0003-4419-353X; Moizs, Mariann/0000-0003-1055-5918; Kovács, Árpád/0000-0002-8469-5764} } @article{MTMT:31611610, title = {Predictive value of multiparametric PET/MR in patients with head and neck squamous cell carcinoma treated with chemoradiotherapy}, url = {https://m2.mtmt.hu/api/publication/31611610}, author = {Kedves, András and Emri, Miklós and K., Fabian and Sipos, Dávid and Freihat, Omar and Tollár, József and Cselik, Zsolt and Bajzik, Gábor and Repa, Imre and Kovács, Árpád and Tóth, Zoltán}, journal-iso = {EUR J NUCL MED MOL I}, journal = {EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING}, volume = {47}, unique-id = {31611610}, issn = {1619-7070}, year = {2020}, eissn = {1619-7089}, pages = {S310-S310}, orcid-numbers = {Sipos, Dávid/0000-0001-9615-1740; Tollár, József/0000-0001-7607-6739; Cselik, Zsolt/0000-0003-2090-4632; Bajzik, Gábor/0000-0002-0996-9294; Kovács, Árpád/0000-0002-8469-5764; Tóth, Zoltán/0000-0002-8096-3813} }